İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

Akademisyen

NURETTİN ERBEN

PROFESÖR

ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Araştırma konuları OpenAlex
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 64
YÖKSİS64 OpenAlex0
Proje 3
Kitap 5
Bildiri 31

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 54
  • Q1 26
  • Q2 8
  • Q3 16
  • Q4 4
WoS (JCR) 55
  • Q1 10
  • Q2 18
  • Q3 7
  • Q4 20
TR Index TR Index

14 makale

OpenAlex atıf yüzdelik
  • Üst %1 6
  • Üst %10 13
  • Ort. 72.4%
  • n 33
Diğer sayımlar

Scopus (SJR)

  • YÖKSİS satırı 78

WoS (JCR)

  • YÖKSİS satırı 79

TR Index

  • YÖKSİS satırı 17 makale

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

38 dergi
Scopus (SJR)
Q1 26 Q2 8 Q3 16 Q4 4
WoS (JCR)
Q1 10 Q2 18 Q3 7 Q4 20
TR Index
14 makale

Makale listesi

  1. 2026 Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry Open Forum Infectious Diseases DOI 10.1093/ofid/ofag099 YÖKSİS SJR Q1 JCR Q2
  2. 2025 Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non‐Invasive Approach Journal of Clinical Laboratory Analysis DOI 10.1002/jcla.70054 YÖKSİS SJR Q1 JCR Q2 OpenAlex 10.1%
  3. 2025 Sequential serum galactomannan as outcome marker for invasive aspergillosis - an exploratory study from the FungiScope® registry. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases DOI 10.1016/j.ijid.2025.108272 YÖKSİS SJR Q1 JCR Q1
  4. 2025 Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3 Turkish Journal of Gastroenterology DOI 10.5152/tjg.2025.24751 YÖKSİS TR Index SJR Q3 JCR Q3
  5. 2025 Bloodstream Infections in Non-ICU Hospitalized Patients: Impact of Pathogen Group on Clinical Outcomes-A Retrospective Cohort Study From Türkiye. Infection and drug resistance DOI 10.2147/IDR.S558264 YÖKSİS SJR Q2 JCR Q2 OpenAlex 74.6%
  6. 2025 Consensus paper on Candida auris by Türkiye EKMUD, THSK of Ministry of Health of the Republic of Türkiye, KLIMUD, TMC, TARD, TYBD and ID-IRI Turkish Journal of Medical Sciences DOI 10.55730/1300-0144.6059 YÖKSİS TR Index SJR Q3 JCR Q2 OpenAlex üst %10 OpenAlex 97.4%
  7. 2025 Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report. American journal of hematology DOI 10.1002/ajh.27565 YÖKSİS SJR Q1 JCR Q1
  8. 2025 Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry. American journal of hematology DOI 10.1002/ajh.70166 YÖKSİS SJR Q1 JCR Q1
  9. 2025 Risk Factors and Treatment Determinants of Mortality in Carbapenem-Resistant Gram-Negative Bloodstream Infections in the Intensive Care Unit Mediterranean Journal of Infection Microbes and Antimicrobials DOI 10.4274/mjima.galenos.2025.25438.21 2 YÖKSİS kaydı YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 25.4%
  10. 2024 Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 eClinicalMedicine DOI 10.1016/j.eclinm.2024.102553 YÖKSİS SJR Q1 JCR Q1
  11. 2024 Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study. The Journal of infection DOI 10.1016/j.jinf.2024.106229 YÖKSİS SJR Q1 JCR Q1
  12. 2024 Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey Infection DOI 10.1007/s15010-023-02169-7 YÖKSİS SJR Q1 JCR Q2
  13. 2024 Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry Haematologica DOI 10.3324/haematol.2023.284678 YÖKSİS SJR Q1 JCR Q1
  14. 2023 Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study. The Lancet. Infectious diseases DOI 10.1016/S1473-3099(22)00872-6 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.8%
  15. 2023 Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry. International journal of antimicrobial agents DOI 10.1016/j.ijantimicag.2023.106952 YÖKSİS SJR Q1 JCR Q1
  16. 2022 Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey Turk J Gastroenterol DOI 10.5152/tjg.2022.21271 3 YÖKSİS kaydı YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 56.5%
  17. 2022 Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey. The Turkish Journal of Gastroenterology YÖKSİS TR Index SJR Q3 JCR Q4
  18. 2022 In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey. Turkish Journal of Gastroenterology DOI 10.5152/tjg.2022.21834 3 YÖKSİS kaydı YÖKSİS SJR Q3 JCR Q4
  19. 2022 Investigation of the relationship of CO-RADS and CT patterns with laboratory parameters in COVID-19 patients and a new perspective on the total CT scoring system BMC MEDICAL IMAGING DOI 10.1186/s12880-022-00857-8 YÖKSİS SJR Q2 JCR Q3
  20. 2022 Evaluation of prognostic factors in febrile neutropenic patients with hematological malignancies Dahiliye uzmanlari dernegi (DAHUDER) DOI 10.56016/dahudermj.1187628 YÖKSİS OpenAlex 18.4%

Akademisyenlere dön